The U.S. Government and International Family Planning & Reproductive Health Efforts
This fact sheet examines the U.S. government’s role in family planning and reproductive health (FP/RH) worldwide.
View the Latest: Reproductive Health
Filter
-
-
KFF Examines Key Considerations for the Implementation of Insurance Coverage for Over-the-Counter Contraceptives
News ReleaseWith federal regulators seeking public input on the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover over-the-counter preventive products without a prescription, a new KFF post explores the issues relevant to covering over-the-counter contraceptives.
-
Considerations for Covering Over-the-Counter Contraception
Policy WatchIn October 2023, the Departments of the Treasury, Labor, and Health and Human Services issued a request for information to gather public input about the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover OTC preventive services and supplies without a prescription. This policy watch addresses key considerations for the implementation of insurance coverage for non-prescribed OTC contraceptives based on the lessons learned from KFF’s 2023 study of Insurance Coverage of OTC Oral Contraceptives.
-
KFF Examines How Abortion Bans, Misinformation, and State Actions May Affect Access to Contraception
News ReleaseFollowing the Supreme Court’s ruling overturning Roe v. Wade, uncertainty has emerged over whether the right to contraception could also be limited.
-
Large Shares of Black Adults, Hispanic Adults, and Rural Residents are Unsure Whether to Believe Many False Health Claims
News ReleaseDrawing on KFF’s Misinformation Pilot Poll, KFF today released three follow-up reports examining exposure to, and belief in, health misinformation among Black adults, Hispanic adults, and rural communities.
-
Addressing Misinformation in Rural Communities: Snapshot from the KFF Health Misinformation Tracking Poll Pilot
Poll FindingThis report examines the exposure to, and belief in, health misinformation among people living in rural communities, as well as the media sources they use and the trust they place in health information received from various outlets. It is a companion to the KFF Health Misinformation Tracking Poll Pilot.
-
Addressing Misinformation Among Black Adults: Snapshot from the KFF Health Misinformation Tracking Poll Pilot
Poll FindingThis report examines the exposure to, and belief in, health misinformation among Black adults, as well as the media sources they use and the trust they place in health information received from various outlets. It is a companion to the KFF Health Misinformation Tracking Poll Pilot.
-
Addressing Misinformation Among Hispanic Adults: Snapshot from the KFF Health Misinformation Tracking Poll Pilot
Poll FindingThis report examines the exposure to, and belief in, health misinformation among Hispanic adults, as well as the media sources they use and the trust they place in health information received from various outlets. It is a companion to the KFF Health Misinformation Tracking Poll Pilot.
-
KFF Examines Challenges in Navigating Coverage for Opill, the First Over-the-Counter Daily Oral Contraceptive Pill, Coming to Market Next Year
News ReleaseAs Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it.
-
Insurance Coverage of OTC Oral Contraceptives: Lessons from the Field
ReportThis report is based on 35 structured interviews conducted from January to August 2023, with nearly 80 experts and key players such as pharmacists, health plans, and state Medicaid officials involved in the coverage and provision of OTC contraception in seven states with one or more of these coverage approaches (IL, NJ, NM, NY, OR, UT, and WA). It discusses the challenges and successes in coverage under private health insurance and Medicaid and reviews policy options for operationalizing insurance coverage of non-prescribed OTC contraception such as Opill.